FDA approval of LAD gene therapy
Last Thursday, the FDA approved the LAD gene therapy developed by Juan A. Bueren and Elena Almarza, in collaboration with the Adrian Thrasher team. This treatment was licensed to Rocket Pharma, who developed the clinical trial and presented it to the FDA. We believe this is terrific news for the gene therapy field and for ESGCT, as all these advances have come from ESGCT members, and the society has played a fundamental role in favouring this collaboration and in the developm
ForTra gGmbH and the SPARK-BIH team cordially invite you to their joint workshop on GCT in Frankfurt/Main
The ForTra gGmbH (the nonprofit subsidiary of the Else Kröner-Fresenius Foundation for research transfer) and the SPARK-BIH team of the National Strategy for Gene- and Cell-Based Therapies cordially invite you to their joint workshop on GCT in Frankfurt/Main. Join ForTra and the SPARK-BIH team of the National Strategy for Gene- and Cell-Based Therapies for an inspiring, forward-looking workshop on Gene and Cell therapy (GCT) – one of the most dynamic fields shaping t
